RVP
RETRACTABLE TECHNOLOGIES INC
+0.01 (+0.97%)0.69USD912成交股數20.6M市值–本益比(近四季)0.6股價營收比-31.1%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 7.2M-31% | 7.2M-13% | 9.4M-9% | 10.1M+67% | 10.4M+37% | 8.3M-42% | 10.3M+0% | 6.0M-24% | 7.6M | 14.3M | 10.3M | 8.0M |
| 營業成本 | 7.0M | 8.0M | 11.0M | 8.4M | 10.6M | 8.3M | 10.4M | 6.4M | 5.7M | 12.7M | 6.0M | 7.6M |
| 毛利 | 191K-278% | −838K+43773% | −1.5M+10230% | 1.7M-501% | −107K-106% | −2K-100% | −15K-100% | −420K-211% | 1.9M | 1.5M | 4.3M | 377K |
| 毛利率 | 2.7% | -11.7% | -16.2% | 16.7% | -1.0% | -0.0% | -0.1% | -7.0% | 25.0% | 10.8% | 41.8% | 4.7% |
| 研發費用 | 187K | 170K | 125K | 199K | 160K | 191K | 175K | 199K | 142K | 162K | 151K | 139K |
| 銷售管理費用 | 3.6M | 3.4M | 3.1M | 3.6M | 3.2M | 2.9M | 3.2M | 3.7M | 3.3M | 2.7M | 3.7M | 3.7M |
| 營業利益 | −5.1M+0% | −6.2M+32% | −7.7M+50% | −3.7M-37% | −5.1M+72% | −4.7M+68% | −5.1M+449% | −5.8M+15% | −3.0M | −2.8M | −936K | −5.0M |
| 營業利益率 | -71.5% | -85.9% | -81.7% | -36.2% | -49.1% | -56.4% | -49.6% | -95.6% | -39.3% | -19.4% | -9.1% | -63.1% |
| 稅後淨利 | 2.8M-3336% | −4.2M-60% | −2.3M+22% | 371K-103% | −87K-120% | −10.5M+14296% | −1.9M-53% | −14.2M+266% | 429K | −73K | −4.1M | −3.9M |
| 淨利率 | 39.3% | -58.9% | -24.9% | 3.7% | -0.8% | -126.6% | -18.6% | -234.9% | 5.7% | -0.5% | -39.3% | -48.5% |
| 稀釋 EPS | 0.09 | -0.14-60% | -0.09+29% | 0.01-102% | 0.00-100% | -0.35 | -0.07-50% | -0.48+269% | 0.01 | 0.00 | -0.14 | -0.13 |
| 稀釋股數 | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 29.9M | 30.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.6M | 2.8M | 2.6M | 3.4M | 3.0M | 3.4M | 3.9M | 6.9M | 10.0M | 12.7M | 11.3M | 4.1M |
| 應收帳款 | 9.0M | 7.0M | 7.9M | 8.4M | 8.1M | 5.4M | 8.7M | 4.7M | 7.4M | 10.7M | 8.2M | 7.2M |
| 存貨 | 15.9M | 16.4M | 17.2M | 20.4M | 20.4M | 21.2M | 21.3M | 22.0M | 19.5M | 17.6M | 22.5M | 20.9M |
| 總資產 | 142M | 138M | 143M | 146M | 147M | 149M | 158M | 161M | 176M | 180M | 182M | 187M |
| 有息負債 | – | – | 896K | 624K | 718K | 807K | 987K | 1.1M | 1.2M | 1.2M | 1.3M | 1.4M |
| 總負債 | 68.8M | 67.5M | 68.3M | 69.7M | 70.6M | 72.7M | 74.4M | 75.3M | 76.3M | 80.4M | 82.1M | 83.2M |
| 股東權益 | 72.9M | 70.1M | 74.4M | 76.8M | 76.5M | 76.6M | 83.5M | 85.4M | 99.7M | 99.3M | 99.4M | 104M |
| 負債比 | 48.6% | 49.1% | 47.9% | 47.6% | 48.0% | 48.7% | 47.1% | 46.8% | 43.4% | 44.7% | 45.2% | 44.6% |
| 淨現金(現金 − 有息負債) | – | – | 1.7M | 2.8M | 2.3M | 2.6M | 2.9M | 5.8M | 8.9M | 11.4M | 9.9M | 2.8M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.4M-7% | – | – | – | −1.5M | – | – | −2.0M | – | – | – |
| 資本支出 | – | 6K | – | – | – | 87K | – | – | 226K | – | – | – |
| 自由現金流 | – | −1.4M-12% | – | – | – | −1.6M | – | – | −2.2M | – | – | – |
| 折舊攤銷 | – | 1.9M | – | – | – | 1.9M | – | – | 1.9M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -19.1% | – | – | – | -18.8% | – | – | -29.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 38.3M
| Single Reportable | 38.3M | 100.0% | +15.8% |
|---|
主要客戶2025 年度 · 38.3M
| United States Sales | 32.2M | 84.2% | +9.7% |
|---|---|---|---|
| North And South America Sales Excluding United States Sales | 5.1M | 13.2% | +158.1% |
| Other International Sales | 969K | 2.5% | -43.5% |
產品／服務2025 年度 · 38.3M
| Syringes | 24.9M | 65.1% | +10.1% |
|---|---|---|---|
| Easy Point Needles | 11.9M | 31.2% | +33.5% |
| Blood Collection Products | 1.4M | 3.6% | -3.9% |
| Other Products | 44K | 0.1% | -4.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 38.3M | +15.8% | −12.6M | -32.8% | -0.43 | – |
| FY2024 | 33.0M | -24.2% | −11.9M | -36.0% | -0.40 | −13.0M |
| FY2023 | 43.6M | -54.0% | −7.0M | -16.1% | -0.24 | 1.9M |
| FY2022 | 94.8M | -49.7% | 5.1M | 5.4% | 0.15 | −62K |
| FY2021 | 188M | +130.1% | 56.1M | 29.8% | 1.63 | −25.6M |
| FY2020 | 81.9M | +95.9% | 24.2M | 29.6% | 0.80 | −2.1M |
| FY2019 | 41.8M | +25.6% | 3.1M | 7.5% | 0.07 | 1.6M |
| FY2018 | 33.3M | – | −1.3M | -4.0% | -0.06 | −1.6M |